The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung Cancer

INTRODUCTION: In advanced non-small-cell lung cancer (NSCLC), immune checkpoint inhibitors (ICIs) have been reported a better treatment outcome on primary lesions, however, the therapeutic effect on bone metastases has not been clarified. This study investigates the therapeutic effect of ICIs on bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Asano, Yohei, Yamamoto, Norio, Demura, Satoru, Hayashi, Katsuhiro, Takeuchi, Akihiko, Kato, Satoshi, Miwa, Shinji, Igarashi, Kentaro, Higuchi, Takashi, Yonezawa, Hirotaka, Araki, Yoshihiro, Morinaga, Sei, Saito, Shiro, Sone, Takashi, Kasahara, Kazuo, Tsuchiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010859/
https://www.ncbi.nlm.nih.gov/pubmed/35433422
http://dx.doi.org/10.3389/fonc.2022.871675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010859/
https://www.ncbi.nlm.nih.gov/pubmed/35433422
http://dx.doi.org/10.3389/fonc.2022.871675

Ejemplares similares